| Date Filed | Type | Description |
| 08/04/2023 |
4
| Stephan Dietrich A (Founder and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Exercised 93,234 options to buy
@ $0.022, valued at
$2.1k
|
|
| 03/17/2023 |
4
| Branning Todd P. (CFO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 54,200 shares
@ $0 |
|
| 03/17/2023 |
4
| Stephan Dietrich A (CEO and Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 153,000 shares
@ $0 |
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2022 |
4
| RICHMAN ERIC I (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 37,600 options to buy
@ $0.6, valued at
$22.6k
|
|
| 09/12/2022 |
4
| PRENDERGAST FRANKLYN G (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 37,600 options to buy
@ $0.6, valued at
$22.6k
|
|
| 09/12/2022 |
4
| McDougall Gerald J (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 37,600 options to buy
@ $0.6, valued at
$22.6k
|
|
| 09/12/2022 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 37,600 options to buy
@ $0.6, valued at
$22.6k
|
|
| 09/12/2022 |
4
| Ende Eric J (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 37,600 options to buy
@ $0.6, valued at
$22.6k
|
|
| 04/01/2022 |
4
| Mann William Roland (COO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Bought 6,200 shares
@ $1.92, valued at
$11.9k
|
|
| 03/21/2022 |
4
| Branning Todd P. (CFO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $1.81, valued at
$18.1k
|
|
| 03/18/2022 |
4
| Branning Todd P. (CFO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Bought 10,000 shares
@ $1.62, valued at
$16.2k
Bought 10,000 shares
@ $1.74, valued at
$17.4k
|
|
| 03/07/2022 |
4
| RICHMAN ERIC I (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Bought 1,580 shares
@ $1.58, valued at
$2.5k
Bought 1,300 shares
@ $1.72, valued at
$2.2k
Bought 1,000 shares
@ $1.62, valued at
$1.6k
|
|
| 01/25/2022 |
4
| Mann William Roland (COO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 60,180 options to buy
@ $1.58, valued at
$95.1k
|
|
| 01/25/2022 |
4
| Rojas-Caro Sandra (Chief Medical Officer) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 44,592 options to buy
@ $1.58, valued at
$70.5k
|
|
| 01/25/2022 |
4
| Stephan Dietrich A (President and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 306,000 options to buy
@ $1.58, valued at
$483.5k
|
|
| 01/10/2022 |
4
| Branning Todd P. (CFO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $2.52, valued at
$756k
|
|
| 01/10/2022 |
3
| Branning Todd P. (CFO) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 01/05/2022 |
4
| Stephan Dietrich A (President and CEO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Exercised 42,250 options to buy
@ $0.001, valued at
$42.3 |
|
| 01/05/2022 |
4
| Ende Eric J (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 165,803 options to buy
@ $2.95, valued at
$489.1k
|
|
| 01/05/2022 |
3
| Ende Eric J (Director) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 09/24/2021 |
4
| Mann William Roland (COO) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.49, valued at
$87.3k
|
|
| 09/17/2021 |
4
| McDougall Gerald J (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 38,135 options to buy
@ $3.36, valued at
$128.1k
|
|
| 09/17/2021 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 38,135 options to buy
@ $3.36, valued at
$128.1k
|
|
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2021 |
4
| RICHMAN ERIC I (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 38,135 options to buy
@ $3.36, valued at
$128.1k
|
|
| 06/21/2021 |
4
| GOLDSTEIN DOV A MD (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Bought 8,000 shares
@ $4.75, valued at
$38k
|
|
| 05/25/2021 |
4
| Rojas-Caro Sandra (Chief Medical Officer) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 280,000 options to buy
@ $5.01, valued at
$1.4M
|
|
| 05/25/2021 |
4
| Motesharei Kianoush (See Remarks) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 250,000 options to buy
@ $5.01, valued at
$1.3M
|
|
| 05/25/2021 |
3
| Rojas-Caro Sandra (Chief Medical Officer) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 05/25/2021 |
3
| Motesharei Kianoush (See Remarks) has filed a Form 3 on NeuBase Therapeutics, Inc. |
| 05/13/2021 |
4
| McDougall Gerald J (Director) has filed a Form 4 on NeuBase Therapeutics, Inc.|
Txns:
| Granted 92,219 options to buy
@ $4.91, valued at
$452.8k
|
|
| 05/13/2021 |
3
| McDougall Gerald J (Director) has filed a Form 3 on NeuBase Therapeutics, Inc. |
|